DRL seeks a booster from Sputnik V but hurdles in scaling up remain
Even as the company investigates complaints of malpractice in the Ukraine, hurdles in scaling up the Russian vaccine remain the bigger challenge in the near term09-08-2021
09-08-2021
DRL stock falls 10% after missing Q1 estimates, probe by US SEC
The stock fell 10.4 per cent to Rs 4,844.35 (hitting the lower circuit) on Tuesday after reporting lower-than-expected quarterly earnings for Q1FY2228-07-2021
Rockwell Industries ties up with DRL for freezers to store Sputnik V COVID-19 vaccine
According to a release by Rockwell, the vaccine freezer plays a very critical role in the safety of vaccines and its potency as Russias Sputnik V vaccine, made available in India through Dr Reddy's, requires a temperature range of minus -18 degrees celsius, to keep the vaccine stable and potent.09-06-2021
RDIF-DRL caution against fake tie-ups' over Sputnik V supply
The DRL-RDIF said it had not entered into any partnership to supply the Sputnik V vaccine to residential associations28-05-2021
Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL
"We expect to get the approval in the next few weeks," said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL)30-03-2021
Expert panel asks DRL to come back with more data on Sputnik safety
DRL applied for restricted emergency use of Sputnik V last week, has lined up 250 mn doses for Indians over next 12 months24-02-2021
Tech transfer of Russian Covid vaccine Sputnik V kicks off at Indian sites
In September, DRL and RDIF had tied up to conduct clinical trials and distribute the vaccine in India.20-11-2020
DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir
Emergency use authorisation to continue; recently, WHO had raised doubts about efficacy of drug in treatment of Covid-19 patients02-11-2020
Cancer drug licence in US biggest opportunity for DRL
Cancer drug licence in US biggest opportunity for DRLOn a very conservative basis, the drug can add about $300 million to their sales in FY23-FY24.'18-09-2020
DRL launches Avigan for mild Covid-19 infections at Rs 99 a tablet
Drug to be imported from Japan for time being, India manufacturing to start soon19-08-2020